ALKS: Alkermes plc Stocks News on September 13, 2025

ALKS

The Wall Street Journal

5 days ago

Health Care Roundup: Market Talk

Takeda and Alkermes share OX2R drug data for narcolepsy

ALKS

Clinical Trials Arena

5 days ago

Takeda and Alkermes share OX2R drug data for narcolepsy

ALKS

MT Newswires

5 days ago

Alkermes Investigational Narcolepsy Drug Meets Primary, Secondary Endpoints in Phase 2 Study

Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025

ALKS

PR Newswire

5 days ago

Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025

Xoma, a drug royalty specialist, buys another ‘zombie’ biotech

ALKS

BioPharma Dive

24 days ago

Xoma, a drug royalty specialist, buys another ‘zombie’ biotech

Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls

ALKS

TipRanks

3 months ago

Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls

ALKS

MT Newswires

3 months ago

Alkermes' ALKS-2680 Seen as Potential Breakthrough for Narcolepsy, Hypersomnia, BofA Says

ALKS

MT Newswires

3 months ago

UBS Upgrades Alkermes Public to Buy From Neutral, Adjusts Price Target to $42 From $33

Why Is Jazz (JAZZ) Up 7.9% Since Last Earnings Report?

ALKS

Zacks

3 months ago

Why Is Jazz (JAZZ) Up 7.9% Since Last Earnings Report?

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

ALKS

PR Newswire

3 months ago

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences

ALKS

PR Newswire

3 months ago

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences

ALKS

Simply Wall St.

3 months ago

Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 49% Undervaluation?

ALKS

PR Newswire

3 months ago

Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025

ALKS

MT Newswires

4 months ago

Needham Initiates Alkermes Public at Buy With $45 Price Target

ALKS

Insider Monkey

4 months ago

Alkermes plc (ALKS): Among Billionaire Jim Simons’ RenTech’s Small-Cap Stock Picks with Huge Upside Potential

Alkermes First Quarter 2025 Earnings: EPS Beats Expectations

ALKS

Simply Wall St.

4 months ago

Alkermes First Quarter 2025 Earnings: EPS Beats Expectations

Alkermes' Q1 Earnings and Revenues Fall Short of Estimates

ALKS

Zacks

4 months ago

Alkermes' Q1 Earnings and Revenues Fall Short of Estimates

ALKS

MT Newswires

4 months ago

RBC Raises Price Target on Alkermes to $40 From $39, Keeps Sector Perform Rating

ALKS

GuruFocus.com

4 months ago

Alkermes PLC (ALKS) Q1 2025 Earnings Call Highlights: Strong Proprietary Product Growth and ...

ALKS

Zacks

4 months ago

Here's What Key Metrics Tell Us About Alkermes (ALKS) Q1 Earnings

ALKS

MT Newswires

4 months ago

Alkermes Q1 Earnings, Revenue Decline

ALKS

Zacks

4 months ago

Alkermes (ALKS) Misses Q1 Earnings and Revenue Estimates

ALKS

Associated Press Finance

4 months ago

Alkermes: Q1 Earnings Snapshot

Alkermes plc Reports First Quarter 2025 Financial Results

ALKS

PR Newswire

4 months ago

Alkermes plc Reports First Quarter 2025 Financial Results

Do Options Traders Know Something About Alkermes Stock We Don't?

ALKS

Zacks

4 months ago

Do Options Traders Know Something About Alkermes Stock We Don't?

New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)

ALKS

PR Newswire

4 months ago

New Survey Provides Insights into Diagnosis and Treatment Journey for People Living With Alcohol Use Disorder (AUD)

Arcutis Biotherapeutics, Inc. (ARQT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

ALKS

Zacks

4 months ago

Arcutis Biotherapeutics, Inc. (ARQT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

ALKS

MT Newswires

5 months ago

UBS Adjusts Alkermes Public Price Target to $33 From $38, Maintains Neutral Rating

ALKS

Zacks

5 months ago

Earnings Preview: Alkermes (ALKS) Q1 Earnings Expected to Decline

Alkermes to Report First Quarter Financial Results on May 1, 2025

ALKS

PR Newswire

5 months ago

Alkermes to Report First Quarter Financial Results on May 1, 2025

ALKS

MT Newswires

5 months ago

RBC Trims Price Target on Alkermes to $39 From $40, Keeps Sector Perform Rating

Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference

ALKS

PR Newswire

5 months ago

Alkermes to Participate in the 24th Annual Needham Virtual Healthcare Conference

Alkermes begins Phase II trial of drug candidate for idiopathic hypersomnia

ALKS

Clinical Trials Arena

5 months ago

Alkermes begins Phase II trial of drug candidate for idiopathic hypersomnia

ALKS

Zacks

5 months ago

Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680

ALKS

PR Newswire

5 months ago

Alkermes Announces Initiation of Vibrance-3 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Idiopathic Hypersomnia

ALKS

MT Newswires

6 months ago

Deutsche Bank Adjusts Alkermes Public Price Target to $52 From $40, Maintains Buy Rating

New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder

ALKS

PR Newswire

6 months ago

New National Survey of Healthcare Providers Offers Insights Into the Dynamic and Challenging Treatment Journey for People Living With Schizophrenia or Bipolar I Disorder

Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition?

ALKS

Zacks

6 months ago

Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition?

GE Aerospace Leads Five Stocks Near Buy Points With This Bullish Trait

ALKS

Investor's Business Daily

6 months ago

GE Aerospace Leads Five Stocks Near Buy Points With This Bullish Trait

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points

ALKS

Investor's Business Daily

6 months ago

Cash In On The Luck Of The Irish With 5 St. Patrick's Day Stocks Near Buy Points

ALKS

Zacks

6 months ago

Why Is Alkermes (ALKS) Down 6.6% Since Last Earnings Report?

ALKS

Insider Monkey

6 months ago

Is Alkermes plc (ALKS) the Best Healthcare Stock For Long-Term Investment?

ALKS

Simply Wall St.

6 months ago

Alkermes' (NASDAQ:ALKS) investors will be pleased with their splendid 140% return over the last five years

ALKS

MT Newswires

6 months ago

Alkermes Facing Near-Term Headwinds Across Existing Franchises, Royalties, RBC Says

ALKS

MT Newswires

6 months ago

RBC Initiates Alkermes at Sector Perform With $40 Price Target

ALKS

MT Newswires

6 months ago

UBS Upgrades Alkermes to Neutral From Sell, $38 Price Target

ALKS

Insider Monkey

6 months ago

Alkermes plc (ALKS): Among the Best Psychedelic Stocks to Buy in 2025

Alkermes to Participate in Upcoming Investor Conferences

ALKS

PR Newswire

7 months ago

Alkermes to Participate in Upcoming Investor Conferences

Alkermes plc Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

ALKS

Simply Wall St.

7 months ago

Alkermes plc Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

Alkermes' Q4 Earnings & Revenues Surpass Estimates, Stock Up

ALKS

Zacks

7 months ago

Alkermes' Q4 Earnings & Revenues Surpass Estimates, Stock Up

Alkermes Full Year 2024 Earnings: Beats Expectations

ALKS

Simply Wall St.

7 months ago

Alkermes Full Year 2024 Earnings: Beats Expectations

ALKS

GuruFocus.com

7 months ago

Alkermes PLC (ALKS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Debt-Free Milestone

ALKS

Zacks

7 months ago

Alkermes (ALKS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

ALKS

MT Newswires

7 months ago

Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday

ALKS

Zacks

7 months ago

Alkermes (ALKS) Q4 Earnings and Revenues Surpass Estimates

ALKS

Associated Press Finance

7 months ago

Alkermes: Q4 Earnings Snapshot

ALKS

MT Newswires

7 months ago

Alkermes Q4 Non-GAAP Earnings, Revenue Increase

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025

ALKS

PR Newswire

7 months ago

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025

ALKS

GuruFocus.com

7 months ago

Earnings To Watch: Alkermes PLC (ALKS) Reports Q4 2024 Result

ALKS

MT Newswires

7 months ago

Deutsche Bank Initiates Coverage on Alkermes Public With Buy Rating, $40 Price Target

ALKS

Zacks

7 months ago

What Analyst Projections for Key Metrics Reveal About Alkermes (ALKS) Q4 Earnings

Are orexins the next golden child of neuroscience?

ALKS

Pharma Voice

7 months ago

Are orexins the next golden child of neuroscience?

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025

ALKS

PR Newswire

7 months ago

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025

ALKS

MT Newswires

7 months ago

BofA Adjusts Price Target on Alkermes Public to $33 From $31

ALKS

MT Newswires

7 months ago

Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing

Onera’s validation trial of home polysomnography sleep device succeeds

ALKS

Clinical Trials Arena

8 months ago

Onera’s validation trial of home polysomnography sleep device succeeds

Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ALKS

PR Newswire

8 months ago

Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ALKS

Simply Wall St.

8 months ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Alkermes plc (NASDAQ:ALKS)?

ALKS

MT Newswires

9 months ago

Alkermes Insider Sold Shares Worth $1,961,406, According to a Recent SEC Filing

Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound?

ALKS

Zacks

9 months ago

Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound?

Ultragenyx (RARE) Down 6.8% Since Last Earnings Report: Can It Rebound?

ALKS

Zacks

9 months ago

Ultragenyx (RARE) Down 6.8% Since Last Earnings Report: Can It Rebound?

ALKS

MT Newswires

9 months ago

Alkermes Insider Sold Shares Worth $441,550, According to a Recent SEC Filing

Illumina (ILMN) Down 9.3% Since Last Earnings Report: Can It Rebound?

ALKS

Zacks

9 months ago

Illumina (ILMN) Down 9.3% Since Last Earnings Report: Can It Rebound?

Glaxo (GSK) Down 6.6% Since Last Earnings Report: Can It Rebound?

ALKS

Zacks

9 months ago

Glaxo (GSK) Down 6.6% Since Last Earnings Report: Can It Rebound?

Why Is Incyte (INCY) Up 2.1% Since Last Earnings Report?

ALKS

Zacks

10 months ago

Why Is Incyte (INCY) Up 2.1% Since Last Earnings Report?

Axsome Therapeutics eyes approval after Phase III narcolepsy win

ALKS

Clinical Trials Arena

10 months ago

Axsome Therapeutics eyes approval after Phase III narcolepsy win

ALKS

PR Newswire

10 months ago

Alkermes to Participate in Upcoming Investor Conferences

ALKS

Zacks

10 months ago

Are Options Traders Betting on a Big Move in Alkermes (ALKS) Stock?

ALKS

MT Newswires

10 months ago

Alkermes Insider Sold Shares Worth $1,774,576, According to a Recent SEC Filing

Alkermes to Participate in Two Upcoming Investor Conferences

ALKS

PR Newswire

10 months ago

Alkermes to Participate in Two Upcoming Investor Conferences

Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences

ALKS

PR Newswire

10 months ago

Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences

ALKS

MT Newswires

10 months ago

Stifel Upgrades Alkermes to Buy From Hold, Adjusts Price Target to $36 From $25

Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down

ALKS

Zacks

a year ago

Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down

Alkermes Third Quarter 2024 Earnings: EPS Misses Expectations

ALKS

Simply Wall St.

a year ago

Alkermes Third Quarter 2024 Earnings: EPS Misses Expectations

ALKS

GuruFocus.com

a year ago

Alkermes PLC (ALKS) Q3 2024 Earnings Call Highlights: Strong Proprietary Product Growth and ...

ALKS

Zacks

a year ago

Alkermes (ALKS) Reports Q3 Earnings: What Key Metrics Have to Say

ALKS

MT Newswires

a year ago

Sector Update: Health Care Stocks Flat to Higher Premarket Thursday

ALKS

Zacks

a year ago

Alkermes (ALKS) Lags Q3 Earnings and Revenue Estimates

ALKS

MT Newswires

a year ago

Alkermes' Q3 Non-GAAP Earnings Rise, Revenue Falls

ALKS

Associated Press Finance

a year ago

Alkermes: Q3 Earnings Snapshot

Alkermes plc Reports Third Quarter 2024 Financial Results

ALKS

PR Newswire

a year ago

Alkermes plc Reports Third Quarter 2024 Financial Results

ALKS

GuruFocus.com

a year ago

Alkermes PLC (ALKS) Q3 2024 Earnings Report Preview: What to Expect

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

ALKS

Zacks

a year ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

ALKS

Zacks

a year ago

Alkermes (ALKS) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Alkermes to Report Third Quarter Financial Results on October 24, 2024

ALKS

PR Newswire

a year ago

Alkermes to Report Third Quarter Financial Results on October 24, 2024

Alkermes Stock Jumps Nearly 30% In 3 Months After Hefty Profits

ALKS

Investor's Business Daily

a year ago

Alkermes Stock Jumps Nearly 30% In 3 Months After Hefty Profits

ALKS

Insider Monkey

a year ago

Is Alkermes (ALKS) The Most Undervalued Quality Stock To Buy According To Analysts?

ALKS

Zacks

a year ago

Here's Why Alkermes (ALKS) is a Strong Momentum Stock

ALKS

Zacks

a year ago

Here's Why Alkermes (ALKS) is a Strong Growth Stock

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

ALKS

Zacks

a year ago

Latest Alkermes plc (ALKS) News on September 13, 2025

Share on Social Networks: